Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10172830 | 0.95 | ALDH1A1 (0.50) | ALDH1A1LMNAKMT2ATSHRMAPT | |
| SCHEMBL10172879 | 0.89 | ALDH1A1 (0.52) | ALDH1A1LMNAKMT2ATSHRMAPT | |
| SCHEMBL31337846 | 0.87 | ALDH1A1 (0.59) | ALDH1A1LMNAKMT2ATSHRMAPT | |
| SCHEMBL15256939 | 0.84 | ALDH1A1 (0.59) | ALDH1A1LMNAKMT2ATSHRMAPT | |
| SCHEMBL11039202 | 0.81 | ALDH1A1 (0.62) | ALDH1A1LMNAKMT2ATSHRMAPT | |
| SCHEMBL891541 | 0.80 | ALDH1A1 (0.66) | ALDH1A1LMNAKMT2ATSHRMAPT | |
| SCHEMBL27782256 | 0.80 | ALDH1A1 (0.52) | ALDH1A1LMNAKMT2ATSHRMAPT | |
| SCHEMBL15999899 | 0.80 | ALDH1A1 (0.55) | ALDH1A1LMNAKMT2ATSHRMAPT | |
| SCHEMBL7755246 | 0.80 | ALDH1A1 (0.55) | ALDH1A1LMNAKMT2ATSHRMAPT | |
| SCHEMBL25291024 | 0.79 | ALDH1A1 (0.64) | ALDH1A1LMNAKMT2ATSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9200098-B2 | Radiation-sensitive composition and compound | JSR CORPORATION (JP) | 2015-12-01 | — | — | US | disclosed |
| US-9200098-B2 | Radiation-sensitive composition and compound | JSR CORPORATION (JP) | 2015-12-01 | — | — | US | disclosed |
| US-20120164582-A1 | RADIATION-SENSITIVE COMPOSITION AND COMPOUND | JSR CORPORATION (JP) | 2012-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120164582-A1 | RADIATION-SENSITIVE COMPOSITION AND COMPOUND | RAD51, RER1, ATP6AP1 | ALDH1A1 1300/4885LMNA 3748/4885KMT2A 2301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.